Acute Agitation And Aggression Treatment Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact
Discover trends, market shifts, and competitive outlooks for the acute agitation and aggression treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has The Acute Agitation And Aggression Treatment Market Growth Evolved From 2024 To 2025, And What’s Ahead?
In the past few years, the market for the treatment of acute agitation and aggression has experienced substantial growth. The size of this market is foreseen to grow from $5.72 billion in 2024 to $6.05 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth in the historic period could include improvements in pharmacology, a surge in clinical research, regulatory authorizations, an upsurge in acute agitation and aggression incidents, and greater awareness of mental health.
The market for treatment of acute agitation and aggression is projected to witness robust growth in the upcoming years, reaching $7.77 billion by 2029 with a compound annual growth rate (CAGR) of 6.4%. This substantial growth during the forecast period is likely due to factors such as an increase in the aged population, an expansion of the healthcare infrastructure, higher investments in the pharmaceutical industry, a hike in home-based care services, and a rise in disposable income. Key trends to watch in the forecast period are non-pharmacological treatments, precision medicine, AI and predictive analytics, as well as community-based support and industry collaboration.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13078&type=smp
What Are the Core Market Drivers Propelling Growth in the Acute Agitation And Aggression Treatment Industry?
Anticipations of a rise in dementia incidences are set to fuel the expansion of the acute agitation and aggression treatment market. Dementia is a condition that is characterized by memory impairment, cognitive dysfunction, and challenges in performing daily tasks. Often, patients with dementia exhibit symptoms of agitation, which can be identified through restless behavior, repetitive actions, or frequent hand movements. The role of acute agitation and aggression treatment in dementia is significant as it minimizes the chance of severe symptoms, enhances the patient’s life quality, and deals with the root cause of the agitation. For example, the Australian Institute of Health and Welfare, a government agency based in Australia, reported in February 2023 that around 401,300 Australians were predicted to have dementia in 2022, with the numbers expected to double to 849,300 by 2058. Hence, the escalating prevalence of dementia is serving as a catalyst for the acute agitation and aggression treatment market’s growth.
How Is the Acute Agitation And Aggression Treatment Market Segmented?
The acute agitation and aggression treatment market covered in this report is segmented –
1) By Treatment Approach: Behavioral Approaches, Environmental Interventions, Pharmacologic Approaches
2) By Drug Class: Anti-Psychotics, Benzodiazepines, Other Drug Classes
3) By Route of Administration: Oral, Intramuscular, Other Routes of Administrations
4) By Indication: Schizophrenia, Dementia, Bipolar Disorder, Depression, Drug-Induced Agitation And Aggression, Alcohol Withdrawal, Other Indications
5) By End User: Hospitals And Ambulatory Surgical Centers, Psychiatric Care Facilities, Other End Users
Subsegments:
1) By Box Style: Standard Box Action Cameras, Modular Box Action Cameras
2) By Cube Style: Compact Cube Action Cameras, Cube Cameras with Integrated Mounts
3) By Bullet Style: Long, Cylindrical Action Cameras, Mountable Bullet Cameras
4) By Periscope & 360°: 360-Degree Cameras, Periscope Cameras
5) By Other Types: Wearable Action Cameras, Drone Action Cameras, Specialty Action Cameras
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13078&type=smp
Which Regions Are Driving the Next Phase of the Acute Agitation And Aggression Treatment Market Growth?
The countries covered in the acute agitation and aggression treatment market market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
What Key Trends Are Shaping the Future of the Acute Agitation And Aggression Treatment Market?
In the field of acute agitation and aggression treatment, leading corporations are pioneering new products and seeking regulatory approval. One such breakthrough is IGALMI (dexmedetomidine), a novel treatment for patients suffering from agitation linked to conditions such as schizophrenia and bipolar disorder. IGALMI (dexmedetomidine) is administered via a sublingual film and intended for persons diagnosed with either schizophrenia or bipolar I or II. In April 2022, BioXcel Therapeutics Inc., a biopharmaceutical firm based in the U.S., secured FDA approval for IGALMI (dexmedetomidine). This medication has a fast onset, taking effect in mere minutes, and a short duration, with its impact lasting around two hours. It promises to substantially enhance the current treatments for patients with serious or critical health conditions.
View the full report here:
How Is the Acute Agitation And Aggression Treatment Market Defined and What Are Its Core Parameters?
Acute agitation and aggression treatment refers to the medical and therapeutic interventions to manage and reduce the sudden onset of restlessness, irritability, and hostility in patients. These agitated and aggressive behaviors can be symptoms of various underlying conditions, including psychiatric disorders, neurological disorders, or substance use or withdrawal effects.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13078
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
